Patents by Inventor Myron Beigler
Myron Beigler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6329433Abstract: A pesticide and a method of using the pesticide to kill invertebrates, especially insects, arachnids and larvae. The method is to prepare a mixture of a carrier with the pesticide and apply the mixture to the insects, arachnids and larvae and their habitat. The pesticide is a neurotransmitter affector utilizing octopamine receptor sites in the insects, arachnids and larvae. The affector agent is a chemical having a six membered carbon ring having substituted thereon at least one oxygenated functional group. The affector agent is a chemical component of a plant essential oil and is naturally occurring. Deposition of the chemicals of the present invention on a surface provides residual toxicity for up to 30 days. Various carriers for the affector agent are disclosed. The chemicals of the present invention deter feeding of insects, arachnids and larvae and also retard growth of the larvae of the insects and arachnids.Type: GrantFiled: December 22, 1999Date of Patent: December 11, 2001Assignee: Ecosmart Technololies, IncorporatedInventors: Steven M. Bessette, Myron A. Beigler
-
Patent number: 6183767Abstract: A pesticide and a method of using the pesticide to kill invertebrates, especially insects, arachnids and larvae. The method is to prepare a mixture of a carrier with the pesticide and apply the mixture to the insects, arachnids and larvae and their habitat. The pesticide is a neurotransmitter affector utilizing octopamine receptor sites in the insects, arachnids and larvae. The affector agent is a chemical having a six membered carbon ring having substituted thereon at least one oxygenated functional group. The affector agent is a chemical component of a plant essential oil and is naturally occurring. Deposition of the chemicals of the present invention on a surface provides residual toxicity for up to 30 days. Various carriers for the affector agent are disclosed. The chemicals of the present invention deter feeding of insects, arachnids and larvae and also retard growth of the larvae of the insects and arachnids.Type: GrantFiled: April 8, 1998Date of Patent: February 6, 2001Assignee: Ecosmart Technologies, IncorporatedInventors: Steven M. Bessette, Myron A. Beigler
-
Patent number: 6004569Abstract: A pesticide and a method of using the pesticide to kill invertebrates, especially insects, arachnids and larvae. The method is to prepare a mixture of a carrier with the pesticide and apply the mixture to the insects, arachnids and larvae and their habitat. The pesticide is a neurotransmitter affector utilizing octopamine receptor sites in the insects, arachnids and larvae. The affector agent is a chemical having a six membered carbon ring having substituted thereon at least one oxygenated functional group. The affector agent is a chemical component of a plant essential oil and is naturally occurring. Deposition of the chemicals of the present invention on a surface provides residual toxicity for up to 30 days. Various carriers for the affector agent are disclosed. The chemicals of the present invention deter feeding of insects, arachnids and larvae and also retard growth of the larvae of the insects and arachnids.Type: GrantFiled: June 6, 1997Date of Patent: December 21, 1999Assignee: Ecosmart Technologies, Inc.Inventors: Steven M. Bessette, Myron A. Beigler
-
Patent number: 5084379Abstract: A method for identifying and quantifying chymopapain-specific IgE antibody levels in patient serum comprising binding chymopapain-specific IgE, if any, in the serum with chymopapain adhering to an insoluble support, conjugating the serum IgE with a labeled anti-IgE antibody, and measuring the level of labeled compound bound to the insoluble support or in the solution removed therefrom. Special reagents and their manufacture are also disclosed.Type: GrantFiled: May 25, 1990Date of Patent: January 28, 1992Assignee: BioWhittaker, Inc.Inventors: Emanuel Calenoff, Ruth M. Jones, Yuh-Geng Tsay, Myron A. Beigler
-
Patent number: 4963356Abstract: A storage-stable, high potency allergenic extract is prepared by ultrafiltration, retaining fractions having molecular weights of from 1000 to 100,000, and drying the retained fraction to a moisture content of less than one weight percent. The extract can also be pretreated with amylase before ultrafiltration, treated with affinity chromatography before drying, and/or treated with gamma radiation after drying.Type: GrantFiled: April 20, 1987Date of Patent: October 16, 1990Assignee: Minnesota Mining and Manufacturing CompanyInventors: Emanuel Calenoff, Myron A. Beigler, Gerald L. Friesen, James L. Nichols
-
Patent number: 4741344Abstract: A non-invasive, external ear canal electrode useful for transmitting sound stimulus to an ear canal and for conducting electrical signals picked up from the ear canal epidermal surface including a tube comprising electroconductive metal and having a resilient plastic foam element impregnated with an electrolytically conductive medium attached to the end to be placed in the ear.Type: GrantFiled: November 17, 1986Date of Patent: May 3, 1988Assignee: Nicolet Instrument CorporationInventors: Hal C. Danby, Myron A. Beigler
-
Patent number: 4716120Abstract: A storage-stable, high potency allergenic extract is prepared by ultrafiltration, retaining fractions having molecular weights of from 1000 to 100,000, and treating the solution with gel polymer and/or carbon absorbents. The extract is dried to a moisture content of less than one weight percent water. The purified solution and aqueous reconstituted solutions of the dried extract provide a transparent, colorless solution which has greatly increased stability, remaining transparent and colorless for extended periods.Type: GrantFiled: November 25, 1985Date of Patent: December 29, 1987Assignee: Minnesota Mining and Manufacturing CompanyInventors: Yuh-Geng Tsay, Myron A. Beigler, Emanuel Calenoff, Gerald L. Friesen, James L. Nichols
-
Patent number: 4622975Abstract: A non-invasive, external ear canal electrode useful for transmitting sound stimulus to an ear canal and for conducting electrical signals picked up from the ear canal epidermal surface including a tube comprising electroconductive metal and having a resilient plastic foam element impregnated with an electrolytically conductive medium attached to the end to be placed in the ear.Type: GrantFiled: September 27, 1982Date of Patent: November 18, 1986Assignee: Minnesota Mining and Manufacturing CompanyInventors: Hal C. Danby, Myron A. Beigler
-
Patent number: 4601294Abstract: A non-invasive, external ear canal electrode useful for transmitting sound stimulus to an ear canal and for conducting electrical signals picked up from the ear canal epidermal surface comprising an electroconductive tube having a resilient annnular sensor comprising a silver conductor attached to the end to be placed in the ear.Type: GrantFiled: September 27, 1982Date of Patent: July 22, 1986Assignee: Minnesota Mining and Manufacturing CompanyInventors: Hal C. Danby, Myron A. Beigler
-
Patent number: 4592370Abstract: A non-invasive, external ear canal electrode and connector therefor useful for transmitting sound stimulus to an ear canal and for conducting electrical signals picked up from the ear canal epidermal surface. The electrode comprises an electro-conductive tube having resilient plastic foam elements attached to the end to be placed in the ear. One foam element is electro-conductive and impregnated with an electrolytically conductive medium, and the cells of the other sound absorbing elements are filled with air.Type: GrantFiled: November 26, 1982Date of Patent: June 3, 1986Assignee: Minnesota Mining and Manufacturing CompanyInventors: John J. Lee, Arthur F. Avila, Hal C. Danby, Myron A. Beigler
-
Patent number: 4499065Abstract: A chymopapain derivative having the enzymatic activity reduced by at least 95% while retaining the original allergenic activity of at least 90% is suitable for skin testing to detect allergic hypersensitivity to chymopapain and for treating patients exhibiting allergic hypersensitivity to chymopapain. The enzymatic activity can be blocked by reacting thiol groups of the enzyme with and iodoacetic acid, bromoacetic acid, or a salt, ester or amide derivative thereof, under conditions which block the undesirable enzymatic activity while retaining the desired allergenic activity.Type: GrantFiled: April 29, 1983Date of Patent: February 12, 1985Assignee: Axonica, Inc.Inventors: Emanuel Calenoff, Ruth M. Jones, Yuh-Geng Tsay, Myron A. Beigler
-
Patent number: 4335835Abstract: A portable device for accurately metering a liquid for intravenous or enteric infusion into a patient's body in which the pressure from a pressure source is utilized to pressurize the liquid and the pressurized liquid becomes the sole driving force to meter and to infuse the liquid into the body. The pressurized liquid is applied alternately to one of a pair of flexible liquid bladders the other one being connected to a discharge device such as a tube so that, as one liquid bladder is filled with pressurized liquid, the other bladder is emptied into the patient. The expanding liquid bladder and the contracting liquid bladder cooperate with a teeter totter type control which applies pressure to the contracting liquid bladder and is damped to control the rate of expansion and contraction. The position of the teeter totter controls the valving for applying pressurized fluid from one side to the opposite by alternatively selecting channels of fluid flow to each liquid bladder.Type: GrantFiled: June 20, 1980Date of Patent: June 22, 1982Assignee: Anatros CorporationInventors: Myron A. Beigler, Hal C. Danby
-
Patent number: 4282863Abstract: The disclosure is of a method for preparing a stable, dry-packaged, sterile, nutrient composition which upon addition of sterile, pyrogen-free water is suitable for intravenous administration to a mammal, including a human. The method comprises providing the nutrients in a specific dry form and state of physical purity acceptable for intravenous administration, sealing the nutrients in a particular type of container adapted to receive and dispense sterile fluids and subjecting the container and its sealed contents to a sterilizing, nondestructive dose of ionizing radiation. The method results in a packaged, sterile nutrient composition which may be dissolved by the addition of sterile, pyrogen-free, water. The resulting aqueous intravenous solution may be safely administered to a mammal, including a human, in need of nutrient therapy.Type: GrantFiled: July 20, 1978Date of Patent: August 11, 1981Inventors: Myron A. Beigler, Amin J. Khoury
-
Patent number: 4237881Abstract: A portable device for accurately metering a liquid for intravenous or enteric infusion into a patient's body in which the pressure from a pressure source is utilized to pressurize the liquid and the pressurized liquid becomes the sole driving force to meter and to infuse the liquid into the body. The pressurized liquid is applied alternately to one of a pair of flexible liquid bladders the other one being connected to a discharge device, such as a tube, so that, as one liquid bladder is filled with pressurized liquid, the other bladder is emptied into the patient. The expanding liquid bladder and the contracting liquid bladder cooperate with a teeter totter type control which applies pressure to the contracting liquid bladder and is damped to control the rate of expansion and contraction. The position of the teeter totter controls the valving for applying pressurized fluid from one side to the opposite by alternatively selecting channels of fluid flow to each liquid bladder.Type: GrantFiled: December 26, 1978Date of Patent: December 9, 1980Assignee: Anatros CorporationInventors: Myron A. Beigler, Hal C. Danby
-
Patent number: 4029773Abstract: Compositions and method for treating, or reducing the occurrence, of stomach and duodenum ulcers. The compositions and methods are characterized by the administration of a composition containing (dry weight basis) 10 to 40% sucrose; 10 to 40% glucose; 12 to 20% amino acids and 7.5 to 12% lipids. The composition is typically administered orally as an aqueous liquid emulsion.Type: GrantFiled: May 25, 1973Date of Patent: June 14, 1977Assignee: Syntex (U.S.A.) Inc.Inventors: Myron A. Beigler, Ronald J. Amen
-
Patent number: 4003992Abstract: A highly efficient process for preparing a nutritionally acceptable mixture of amino acids from erythrocytes comprises the steps of denaturization, hydrolysis and neutralization, desludging, decolorization, deionization, concentration and sterilization.Type: GrantFiled: June 16, 1975Date of Patent: January 18, 1977Assignee: Syntex (U.S.A.) Inc.Inventors: Myron A. Beigler, William B. Benken, Jorge J. Nassar
-
Patent number: 3993746Abstract: Feeds, medicaments, and baits for inducing exploratory feeding behavior in fish and crustacea which comprise monosodium glutamate and alkali metal aspartate in combination with conventional fish or crustacea food or with a medicament or, in the case of baits, with a non-toxic bulk material.Type: GrantFiled: April 10, 1975Date of Patent: November 23, 1976Assignee: Syntex (U.S.A.) Inc.Inventors: Myron A. Beigler, Ronald J. Amen